TABLE II.
TEA CONSUMPTION (EVER vs. Never) AND UGI CANCERS IN MALES AND FEMALES a
| Control (%) | Esophageal cancer | Gastric cardia adenocarcinoma | Gastric non-cardia adenocarcinoma | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case (%) | OR (95% CI)* | OR (95% CI)# | Case (%) | OR (95% CI)* | OR (95% CI)# | Case (%) | OR (95% CI)* | OR (95% CI)# | ||
| Any tea | 473 (31) | 196 (33) | 1.26 (1.01–1.57) | 1.17 (0.94–1.47) | 228 (38) | 1.21 (0.98–1.49) | 1.15 (0.92–1.43) | 100 (32) | 1.04 (0.78–1.37) | 0.88 (0.66–1.17) |
| Jasmine tea | ||||||||||
| Overall | 422 (28) | 182 (30) | 1.31 (1.04–1.64) | 1.15 (0.92–1.44) | 199 (33) | 1.16 (0.94–1.45) | 1.14 (0.92–1.44) | 88 (28) | 1.03 (0.77–1.37) | 0.85 (0.64–1.15) |
| Male | 390 (35) | 163 (43) | 1.35 (1.06–1.73) | 1.23 (0.96–1.59) | 195 (40) | 1.24 (0.99–1.55) | 1.18 (0.94–1.50) | 86 (36) | 1.10 (0.82–1.49) | 0.92 (0.67–1.26) |
| Female | 32 (8) | 19 (8) | 1.05 (0.58–1.91) | 1.08 (0.59–1.98) | 4 (4) | 0.46 (0.16–1.35) | 0.48 (0.16–1.40) | 2 (3) | 0.32 (0.07–1.36) | 0.36 (0.08–1.571) |
| Black tea | ||||||||||
| Overall | 29 (2) | 6 (1) | 0.63 (0.26–1.55) | 0.57 (0.23–1.41) | 17 (3) | 1.33 (0.71–2.48) | 1.26 (0.67–2.37) | 6 (2) | 0.86 (0.34–2.14) | 0.76 (0.30–1.90) |
| Male | 28 (2) | 6 (2) | 0.66 (0.26–1.62) | 0.58 (0.23–1.45) | 17 (3) | 1.38 (0.74–2.59) | 1.31 (0.69–2.47) | 6 (2) | 0.91 (0.36–2.28) | 0.79 (0.31–2.01) |
| Female | 1 (<1) | 0 | - | - | 0 | - | - | 0 | - | - |
| Other tea | ||||||||||
| Overall | 37 (2) | 10 (2) | 0.80 (0.39–1.64) | 0.85 (0.41–1.76) | 16 (3) | 0.94 (0.51–1.72) | 0.97 (0.53–1.80) | 9 (3) | 1.17 (0.55–2.51) | 1.22 (0.56–2.68) |
| Male | 34 (3) | 8 (2) | 0.73 (0.33–1.61) | 0.82 (0.37–1.84) | 16 (3) | 1.02 (0.55–1.90) | 1.07 (0.57–2.00) | 8 (3) | 1.06 (0.47–2.38) | 1.12 (0.48–2.58) |
| Female | 3 (1) | 2 (1) | - | - | 0 | - | - | 1 (1) | - | - |
a
Reference group is never consumption. Gender was adjusted in the analyses of overall subjects (males and females combined).
*
ORs adjusted for age at interview, geographic regions;
#
ORs adjusted for age at interview, geographic regions, occupation, ever tobacco smoking, ever alcohol drinking, drinking water source, ever scalding-hot food consumption, and family history of esophageal or gastric cancer.